Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

754 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Implementation of reperfusion therapy in ST-segment elevation myocardial infarction. A policy statement from the Belgian Society of Cardiology (BSC), the Belgian Interdisciplinary Working Group on Acute Cardiology (BIWAC) and the Belgian Working Group on Interventional Cardiology (BWGIC).
Claeys MJ, Gevaert S, De Meester A, Evrard P, Legrand V, Vrints C, Berkenboom G, Desmet W, Van Langenhove G, Vranckx P, De Raedt H, Van de Werf F, Van den Branden F; Belgian Society of Cardiology; Belgian Interdisciplinary Working Group on Acute Cardiology; Belgian Working Group on Interventional Cardiology. Claeys MJ, et al. Among authors: de meester a, van den branden f, van langenhove g, van de werf f, de raedt h. Acta Cardiol. 2009 Aug;64(4):541-5. doi: 10.2143/AC.64.4.2041621. Acta Cardiol. 2009. PMID: 19725449 Free article. No abstract available.
Outcome of urgent and elective percutaneous coronary interventions after pharmacologic reperfusion with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab.
Dubois CL, Belmans A, Granger CB, Armstrong PW, Wallentin L, Fioretti PM, López-Sendón JL, Verheugt FW, Meyer J, Van de Werf F; ASSENT-3 Investigators. Dubois CL, et al. Among authors: van de werf f. J Am Coll Cardiol. 2003 Oct 1;42(7):1178-85. doi: 10.1016/s0735-1097(03)00917-3. J Am Coll Cardiol. 2003. PMID: 14522476 Free article. Clinical Trial.
Tomographic and planar quantitation of perfusion defects on technetium 99m-labeled sestamibi scans: evaluation in patients treated with thrombolytic therapy for acute myocardial infarction.
Mortelmans LA, Wackers FJ, Nuyts JL, Scheys IA, Brzostek T, Schiepers CW, Lesaffre EE, Suetens PL, Verbruggen AM, Van de Werf FJ. Mortelmans LA, et al. Among authors: van de werf fj. J Nucl Cardiol. 1995 Mar-Apr;2(2 Pt 1):133-43. doi: 10.1016/s1071-3581(95)80024-7. J Nucl Cardiol. 1995. PMID: 9420778
Antithrombotic therapy in patients with heart valve prostheses.
Hermans H, Vanassche T, Herijgers P, Meuris B, Herregods MC, Van de Werf F, Verhamme P. Hermans H, et al. Among authors: van de werf f. Cardiol Rev. 2013 Jan-Feb;21(1):27-36. doi: 10.1097/CRD.0b013e3182638578. Cardiol Rev. 2013. PMID: 22695380 Review.
Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.
Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, Kalantzi M, Herbots L, Sinnaeve P, Dens J, Maertens J, Rademakers F, Dymarkowski S, Gheysens O, Van Cleemput J, Bormans G, Nuyts J, Belmans A, Mortelmans L, Boogaerts M, Van de Werf F. Janssens S, et al. Among authors: van cleemput j, van de werf f. Lancet. 2006 Jan 14;367(9505):113-21. doi: 10.1016/S0140-6736(05)67861-0. Lancet. 2006. PMID: 16413875 Clinical Trial.
754 results